Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Perinatal Adverse Effects in Newborns with Estimated Loss of Weight Percentile between the Third Trimester Ultrasound and Delivery. The GROWIN Study

dc.contributor.authorGalán Arévalo, María Sonsoles
dc.contributor.authorMahillo Fernández, Ignacio
dc.contributor.authorEsteban, Luis Mariano
dc.contributor.authorAndeyro García, Mercedes
dc.contributor.authorPiñeiro Pérez, Roi
dc.contributor.authorSaénz de Pipaón, Miguel
dc.contributor.authorSavirón Cornudella, Ricardo
dc.date.accessioned2023-06-16T14:21:22Z
dc.date.available2023-06-16T14:21:22Z
dc.date.issued2021-10-10
dc.description.abstractFetal growth restriction has been associated with an increased risk of adverse perinatal outcomes (APOs). We determined the importance of fetal growth detention (FGD) in late gestation for the occurrence of APOs in small-for-gestational-age (SGA) and appropriate-for-gestational-age (AGA) newborns. For this purpose, we analyzed a retrospective cohort study of 1067 singleton pregnancies. The newborns with higher APOs were SGA non-FGD and SGA FGD in 40.9% and 31.5% of cases, respectively, and we found an association between SGA non-FGD and any APO (OR 2.61; 95% CI: 1.35–4.99; p = 0.004). We did not find an increased APO risk in AGA FGD newborns (OR: 1.13, 95% CI: 0.80, 1.59; p = 0.483), except for cesarean delivery for non-reassuring fetal status (NRFS) with a decrease in percentile cutoff greater than 40 (RR: 2.41, 95% CI: 1.11–5.21) and 50 (RR: 2.93, 95% CI: 1.14–7.54). Conclusions: Newborns with the highest probability of APOs are SGA non-FGDs. AGA FGD newborns do not have a higher incidence of APOs than AGA non-FGDs, although with falls in percentile cutoff over 40, they have an increased risk of cesarean section due to NRFS. Further studies are warranted to detect these newborns who would benefit from close surveillance in late gestation and at delivery.
dc.description.departmentDepto. de Medicina
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipHospital Universitario de Villalba
dc.description.statuspub
dc.eprint.idhttps://eprints.ucm.es/id/eprint/71293
dc.identifier.doi10.3390/jcm10204643
dc.identifier.issn2077-0383
dc.identifier.officialurlhttps://doi.org/10.3390/jcm10204643
dc.identifier.relatedurlhttps://www.mdpi.com/2077-0383/10/20/4643/htm
dc.identifier.urihttps://hdl.handle.net/20.500.14352/4799
dc.issue.number20
dc.journal.titleJournal of Clinical Medicine
dc.language.isoeng
dc.page.initial4643
dc.publisherMPDI
dc.rightsAtribución 3.0 España
dc.rights.accessRightsopen access
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/es/
dc.subject.keywordadverse perinatal outcomes
dc.subject.keywordbirthweight
dc.subject.keywordestimated fetal weight
dc.subject.keywordestimated percentile weight
dc.subject.keywordfetal growth velocity
dc.subject.keywordnewborn
dc.subject.keywordgestational age
dc.subject.ucmGinecología y obstetricia
dc.subject.unesco3201.08 Ginecología
dc.titlePerinatal Adverse Effects in Newborns with Estimated Loss of Weight Percentile between the Third Trimester Ultrasound and Delivery. The GROWIN Study
dc.typejournal article
dc.volume.number10
dspace.entity.typePublication

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
jcm-10-04643.pdf
Size:
1.87 MB
Format:
Adobe Portable Document Format

Collections